0001795091-25-000004.txt : 20250122 0001795091-25-000004.hdr.sgml : 20250122 20250121181934 ACCESSION NUMBER: 0001795091-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250122 DATE AS OF CHANGE: 20250121 EFFECTIVENESS DATE: 20250122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OS Therapies Inc CENTRAL INDEX KEY: 0001795091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825118368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-535849 FILM NUMBER: 25543528 BUSINESS ADDRESS: STREET 1: 15825 SHADY GROVE ROAD STREET 2: SUITE 135 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-297-7793 MAIL ADDRESS: STREET 1: 15825 SHADY GROVE ROAD STREET 2: SUITE 135 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: OS THERAPIES Inc DATE OF NAME CHANGE: 20191125 D 1 primary_doc.xml X0708 D LIVE 0001795091 OS Therapies Inc 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 (410) 297-7793 DELAWARE OS THERAPIES Inc Corporation true Paul A. Romness 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Executive Officer Director Founder, Chairman, President and Chief Executive Officer Robert G. Petit 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Executive Officer Chief Medical Officer and Chief Scientific Officer Christopher P. Acevedo 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Executive Officer Chief Financial Officer Gerald Commissiong 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Executive Officer Chief Business Officer John Ciccio 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Director Avril McKean Dieser 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Director Olivier R. Jarry 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Director Theodore F. Search 115 Pullman Crossing Road Suite #103 Grasonville MD MARYLAND 21638 Director Pharmaceuticals Decline to Disclose 06b false 2024-12-31 false true true true false 10000 Brookline Capital Markets 44656 Arcadia Securities, LLC 44656 600 Lexington Avenue 30th Floor New York NY NEW YORK 10022 AL ALABAMA CA CALIFORNIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS LA LOUISIANA MD MARYLAND MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN WY WYOMING false Ceros Financial Services, Inc. 37869 None None 1445 Research Blvd. Suite 530 Rockville MD MARYLAND 20850 AL ALABAMA CA CALIFORNIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS LA LOUISIANA MD MARYLAND MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN WY WYOMING false 10000000 7103000 2897000 After selling $7,103,000 in the Offering, the Issuer has determined to close the Offering. false 34 240000 true 0 0 false OS Therapies Inc /s/Paul A. Romness Paul A. Romness Chief Executive Officer 2025-01-21